Sivik Global Healthcare LLC — 13F Holdings & Portfolio
CIK 1596452 · latest 13F-HR filed 2026-07-20
Sivik Global Healthcare LLC manages $131.7K in 13F-reported U.S. long-equity assets across 34 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are XBI (14.55%), CAH (3.85%), I:BOX17J26 (3.81%).
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
GREENWICH, CT 06831
$131.7K
Long-equity book
34
Distinct positions
2026-06-30
Filed 2026-07-20
+0 / −0 / ↑0 / ↓0
vs 2026-03-31
| Name | Title / Status | Ownership | Type |
|---|
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | STATE STREET SPDR S&P BIOTECH | XBI | 78464A870 | $19.2K | 14.55% | 150,000 | SH |
| 2 | CARDINAL HEALTH | CAH | 14149Y108 | $5.1K | 3.85% | 24,000 | SH |
| 3 | CALL- BSX 100 @ 75 EXP 04/17/2026 | I:BOX17J26 | 99DRG5HW3 | $5.0K | 3.81% | 800 | SH |
| 4 | JOHNSON&JOHNSON | JNJ | 478160104 | $4.9K | 3.71% | 20,000 | SH |
| 5 | MERCK & CO | MRK | 58933Y105 | $4.8K | 3.65% | 40,000 | SH |
| 6 | CENCORA INC | COR | 03073E105 | $4.7K | 3.58% | 15,000 | SH |
| 7 | ELI LILLY & CO | LLY | 532457108 | $4.6K | 3.49% | 5,000 | SH |
| 8 | WATERS CORP | WAT | 941848103 | $4.5K | 3.39% | 15,000 | SH |
| 9 | VERTEX PHARMACEUTICALS INC. | VRTX | 92532F100 | $4.5K | 3.39% | 10,000 | SH |
| 10 | INTUITIVE SURG | ISRG | 46120E602 | $4.1K | 3.15% | 9,000 | SH |
| 11 | ASTRAZENECA PLC | AZN | G0593M107 | $3.9K | 3.00% | 20,000 | SH |
| 12 | THERMO FISHER SCIENTIFIC INC. | TMO | 883556102 | $3.9K | 2.99% | 8,000 | SH |
| 13 | BOSTON SCIENTIFIC CORPORATION | BSX | 101137107 | $3.9K | 2.95% | 62,000 | SH |
| 14 | DANAHER CORP | DHR | 235851102 | $3.8K | 2.88% | 20,000 | SH |
| 15 | TENET HEALTHCARE | THC | 88033G407 | $3.8K | 2.87% | 20,000 | SH |
| 16 | GILEAD SCIENCES INC | GILD | 375558103 | $3.5K | 2.65% | 25,000 | SH |
| 17 | HUMANA INC. | HUM | 444859102 | $3.5K | 2.63% | 20,000 | SH |
| 18 | METTLER TOLEDO | MTD | 592688105 | $3.5K | 2.63% | 2,750 | SH |
| 19 | MCKESSON CORP | MCK | 58155Q103 | $3.5K | 2.63% | 4,000 | SH |
| 20 | AGILENT TECHNOLOGIES INC | A | 00846U101 | $3.4K | 2.60% | 30,000 | SH |
| 21 | STRYKER CORP | SYK | 863667101 | $3.3K | 2.50% | 10,000 | SH |
| 22 | ABBVIE INC | ABBV | 00287Y109 | $3.3K | 2.48% | 15,000 | SH |
| 23 | UNIV HEALTH SVC | UHS | 913903100 | $3.1K | 2.38% | 17,500 | SH |
| 24 | REGENERON PHARMACEUTICALS | REGN | 75886F107 | $3.1K | 2.35% | 4,000 | SH |
| 25 | BIO-RAD LABS A | BIO | 090572207 | $2.8K | 2.12% | 10,000 | SH |
| 26 | BIOGEN INC | BIIB | 09062X103 | $2.8K | 2.09% | 15,000 | SH |
| 27 | UNITEDHEALTH GRP | UNH | 91324P102 | $2.7K | 2.05% | 10,000 | SH |
| 28 | GLOBUS MEDICAL | GMED | 379577208 | $2.6K | 1.96% | 30,000 | SH |
| 29 | ABBOTT LABS | ABT | 002824100 | $2.6K | 1.95% | 25,000 | SH |
| 30 | EDWARDS LIFESCIENCES | EW | 28176E108 | $1.6K | 1.22% | 20,000 | SH |
| 31 | SMITH & NEPHEW | SNN | 83175M205 | $1.6K | 1.21% | 50,000 | SH |
| 32 | ELEVANCE HEALTH INC | ELV | 036752103 | $1.5K | 1.11% | 5,000 | SH |
| 33 | ENCOMPASS HEALTH CORP | EHC | 29261A100 | $1.5K | 1.10% | 15,000 | SH |
| 34 | CVS HEALTH CORP | CVS | 126650100 | $1.4K | 1.09% | 20,000 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-07-20 | $131.7K | 34 | 0001596452-26-000004 |
| 2026-03-31 | 2026-04-15 | $131.7K | 34 | 0001596452-26-000003 |
| 2025-12-31 | 2026-01-21 | $344.6K | 49 | 0001596452-26-000002 |